Equitable Holdings Inc. bought a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 17,547 shares of the company's stock, valued at approximately $1,486,000.
Other hedge funds also recently added to or reduced their stakes in the company. Coastal Bridge Advisors LLC purchased a new stake in Corteva in the second quarter valued at about $1,234,000. Public Employees Retirement System of Ohio purchased a new stake in shares of Corteva during the second quarter worth about $19,642,000. MASTERINVEST Kapitalanlage GmbH acquired a new position in shares of Corteva during the second quarter valued at about $496,000. Capstone Investment Advisors LLC purchased a new position in shares of Corteva in the 2nd quarter valued at approximately $942,000. Finally, Proficio Capital Partners LLC purchased a new position in shares of Corteva in the 2nd quarter valued at approximately $662,000. 81.54% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts have weighed in on CTVA shares. BNP Paribas Exane boosted their target price on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Citigroup lifted their price objective on shares of Corteva from $85.00 to $86.00 and gave the stock a "neutral" rating in a research note on Monday, August 3rd. Weiss Ratings lowered shares of Corteva from a "hold (c+)" rating to a "hold (c)" rating in a report on Monday, August 3rd. Bank of America upped their target price on Corteva from $90.00 to $96.00 and gave the company a "buy" rating in a research report on Monday, July 20th. Finally, Oppenheimer raised their target price on Corteva from $89.00 to $95.00 and gave the stock an "outperform" rating in a research note on Thursday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $91.50.
Check Out Our Latest Research Report on Corteva
Corteva Price Performance
Shares of NYSE:CTVA opened at $84.00 on Friday. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The company's 50 day moving average is $82.69 and its 200 day moving average is $80.54. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a market cap of $56.04 billion, a PE ratio of 55.63, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57.
Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analysts' expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business's quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 3.72 EPS for the current year.
Corteva Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is 47.68%.
Corteva Company Profile
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
